CancerVAX
Company profile on P2PMarketData. CancerVAX is a biotechnology company based in Lehi, UT, founded in 2021. It is raising on StartEngine now.
CancerVAX is a biotechnology company that develops immunotherapy treatments for cancer. The company's technology works by disguising cancer cells to resemble recognizable pathogens like measles, enabling the body's immune system to identify and eliminate them more effectively. Founded in 2021 and based in Lehi, Utah, CancerVAX operates in the cancer treatment sector using pre-clinical technology approaches.
Frequently asked questions about CancerVAX
How much funding has CancerVAX raised?
CancerVAX has raised $1.6M through crowdfunding across 2 rounds tracked by P2PMarketData, from 985 investors.
What is CancerVAX's valuation?
CancerVAX had an indicative valuation of $109M in its 2026 funding round.
Is CancerVAX profitable?
No. CancerVAX reported a net loss of $9.5M for fiscal year 2025.
How many employees does CancerVAX have?
CancerVAX reported 6 employees for fiscal year 2025.
Can I invest in CancerVAX?
Yes. CancerVAX has an open crowdfunding deal on StartEngine.
When was CancerVAX founded?
CancerVAX was founded in March 2021.
Where is CancerVAX based?
CancerVAX is headquartered in Lehi, Utah, United States, and is incorporated in Nevada, United States.
What industry is CancerVAX in?
CancerVAX operates in the Biotechnology industry within the Healthcare sector.